Diabetes Devices Market Players:
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott Laboratories
- ARKRAY, Inc.
- Bayer AG
- Lifescan, Inc.
- B. Braun Melsungen AG
- Dexcom, Inc.
- Insulet Corporation
- Ypsomed AG
- Sanofi
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of diabetes devices is estimated at USD 36.79 billion.
The global diabetes devices market size crossed USD 34.18 billion in 2025 and is likely to register a CAGR of over 8.5%, exceeding USD 77.28 billion revenue by 2035.
North America diabetes devices market is predicted to capture 39.8% share by 2035, driven by increased prevalence of diabetes, rising healthcare expenditure, and strong healthcare network.
Key players in the market include Medtronic plc, Abbott Laboratories, ARKRAY, Inc., Bayer AG, Lifescan, Inc., B. Braun Melsungen AG, Dexcom, Inc., Insulet Corporation, Ypsomed AG, Sanofi.
